Bonraybio Co (TPE:6955) EPS without NRI: NT$4.13 (TTM As of Dec. 2025)


TPE:6955 Bonraybio Co Ltd TPE:6955
65 GF Score
Price NT$120.50
GF Value NT$184.74
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Bonraybio Co EPS without NRI?

Bonraybio Co TPE:6955 65 EPS without NRI is NT$4.13 as of Dec. 2025. GuruFocus rates TPE:6955 with a GF Score™ of 65/100 and a GF Value™ of NT$184.74 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 664 Medical Devices & Instruments companies, Bonraybio Co ranks better than 99.55% on this metric.

Bonraybio Co's earnings per share without non-recurring items for the three months ended in Dec. 2025 was NT$1.20. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was NT$4.13.

During the past 12 months, Bonraybio Co's average earnings per share (NRI) Growth Rate was 37.30% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 267.50% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Bonraybio Co's EPS without NRI or its related term are showing as below:

TPE:6955' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 267.5   Med: 267.5   Max: 267.5
Current: 267.5

During the past 6 years, Bonraybio Co's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 267.50% per year. The lowest was 267.50% per year. And the median was 267.50% per year.

TPE:6955's 3-Year EPS without NRI Growth Rate is ranked better than
99.55% of 664 companies
in the Medical Devices & Instruments industry
Industry Median: 8.15 vs TPE:6955: 267.50

Bonraybio Co's EPS (Diluted) for the three months ended in Dec. 2025 was NT$1.20. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was NT$4.13.

Bonraybio Co's EPS (Basic) for the three months ended in Dec. 2025 was NT$1.20. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was NT$4.14.


Bonraybio Co  (TPE:6955) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Bonraybio Co EPS without NRI Related Terms


Bonraybio Co EPS without NRI Historical Data

* Premium members only.

The historical data trend for Bonraybio Co's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bonraybio Co EPS without NRI Chart

Bonraybio Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EPS without NRI
Get a 7-Day Free Trial -1.98 0.08 1.14 3.00 4.12

Bonraybio Co Quarterly Data
Dec20 Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.02 0.97 0.92 1.04 1.20

TPE:6955 vs ABT, SYK, MDT: EPS without NRI Comparison

For the Medical Devices subindustry, Bonraybio Co's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bonraybio Co PE Ratio without NRI vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bonraybio Co's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Bonraybio Co's PE Ratio without NRI falls into.


TPE:6955
65GF Score
Bonraybio Co Ltd TPE:6955
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bonraybio Co EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$4.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of NT$4.13 mean?
Bonraybio Co (TPE:6955) has a EPS without NRI of NT$4.13 as of Dec. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Bonraybio Co and its competitors. According to the industry distribution chart, Bonraybio Co ranks #3 out of 664 companies in the Medical Devices & Instruments industry, placing it in the top 0.5%.
Is Bonraybio Co's EPS without NRI too high?
Bonraybio Co's current EPS without NRI is NT$4.13. Based on the distribution chart, Bonraybio Co ranks #3 out of 664 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Bonraybio Co has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bonraybio Co's EPS without NRI compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Bonraybio Co ranks #3 out of 664 companies for EPS without NRI. This places Bonraybio Co in the top 1% of its industry — outperforming the majority of peers. The industry median EPS without NRI is 8.15. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Devices & Instruments company?
The median EPS without NRI among Medical Devices & Instruments companies is 8.15, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Bonraybio Co and its competitors. For the Medical Devices & Instruments industry, the median EPS without NRI is 8.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bonraybio Co's current EPS without NRI is NT$4.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bonraybio Co stock overvalued right now?
Based on GuruFocus' analysis, Bonraybio Co (TPE:6955) is currently considered Possible Value Trap. The stock's GF Value™ is NT$184.74, compared to a current price of NT$120.50 — trading 34.8% below its estimated fair value. The current EPS without NRI is NT$4.13. Bonraybio Co's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Bonraybio Co (TPE:6955), the current EPS without NRI is NT$4.13 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bonraybio Co (TPE:6955) Overvalued in 2026?

Based on GuruFocus' analysis, Bonraybio Co stock appears to be undervalued. The current stock price of NT$120.50 is trading 34.8% below its estimated GF Value™ of NT$184.74. GuruFocus considers Bonraybio Co to be Possible Value Trap.

Key valuation signals for TPE:6955:

  • EPS without NRI: NT$4.13
  • GF Value™: NT$184.74 vs. price of NT$120.50 (34.8% below fair value)
  • GF Score™: 65/100 with 4 warning signs

No single metric tells the full story. See the TPE:6955 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bonraybio Co Business Description

Address No. 118, Gongye 9th Road, 4th Floor, Dali District, Taichung City, TWN
Bonraybio Co Ltd engages in research, development, and manufacturing of vitro diagnostic devices. The firm produces semen quality analyzers and Semen Analysis Systems for the clinic.
65GF Score

Get the complete analysis for TPE:6955

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$120.50
Price
NT$184.74
GF Value